PharmaCyte Biotech Inc (PMCB)

[1234jklm]

I read about that liver cancer drug too


If cypcaps is approved as a pre operation procedure for all tumors the commercial value of the technology would be tens of billions I believe.

And it’s revenue would be worldwide for any big pharma that owned it.

As concerns mount over outlays for prescription drugs, a new report finds that global spending on oncology treatments reached $100 billion last year, which represented a 10.3% increase from the previous year and a substantial rise from $75 billion spent five years ago.May 5, 2015

That was 3 years ago. So with compound interest, not to mention the more expensive immuno therapies now being used it should be 133 million.

Current checkpoint inhibitors each have a list price near $150,000 a year. A combination of Yervoy and Opdivo, approved by the Food and Drug Administration for advanced or inoperable melanoma, has a cost of $256,000 a year for patients who respond to the treatment.Apr 3, 2017[/quote

And this is a current and unmet medical need in the case of pancreatic cance



And then there’s diabetes:

According to the leading diabetes website, the American Diabetes Association, the cost associated with diagnosed diabetes was $245 billion in 2012 compared to $174 billion in 2007. That is a 41% increase in just a period of five years. Out of the $245 billion, $176 billion were the direct medical costs of diabetes.Jul 12, 2018

]


And that’s just America. How much will diabetes cost China?

I don’t think many understand how immense the market for a tumor shrinking technology is actually worth or how many pharma companies revenue it might threaten.

And this technology already works in canines as shown in the 2014 study and in humans in the Lohr phase one studies.

The only thing in doubt now is the ind submission date imho. And that’s a matter of when not if.

I really think any mainstream publicity will blow this share price out of the water.

One of the issues with the company is it’s listing on the otc market where there are some pretty scammy companies. I don’t see any other otc company with the level of oncologists or entrepreneurs this company has attracted.

Once this is listed on Nasdaq or partnered with a big pharma or foundation it’s merits will become clear to all. At the moment it’s hiding under a bushel.